Combination therapy with DNA methyltransferase inhibitors in hematologic malignancies

@article{Gore2005CombinationTW,
  title={Combination therapy with DNA methyltransferase inhibitors in hematologic malignancies},
  author={Steven D Gore},
  journal={Nature Clinical Practice Oncology},
  year={2005},
  volume={2 Suppl 1},
  pages={S30-S35}
}
A variety of epigenetic changes contribute to transcriptional dysregulation in myelodysplastic syndromes (MDSs) and acute myeloid leukemia (AML). DNA methyltransferase (DNMT) inhibitors—azacitidine and decitabine—have significant activity in the treatment of MDS. Despite marked activity in myeloid malignancy, monotherapy with DNMT inhibitors is limited by low complete and partial response rates (7–20%) and median response durations of 15 months. As with classical cytotoxic therapy, the… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 32 extracted citations

DNA methyltransferase inhibition reverses epigenetically embedded phenotypes in lung cancer preferentially affecting polycomb target genes.

Clinical cancer research : an official journal of the American Association for Cancer Research • 2014
View 1 Excerpt

References

Publications referenced by this paper.
Showing 1-10 of 21 references

Clinical benefit and survival

HI Saba
2005

Efficacy of lenalidomide in MDS

D Douer
N Engl J Med • 2005

Changes in promoter methylation and gene expression in patients with MDS and MDSAML treated with 5azacitidine and sodium phenylbutyrate [ abstract ]

G Garcia-Manero
Blood • 2004

Myelodysplastic syndromes

B. J Clin Oncol
List AF et al • 2004

New paradigm in the management of myelodysplastic syndromes

A List
Cancer Control • 2004

Phase I study of oral

G Garcia-Manero
2004

Phase I study of oral suberoylanilide hydroxamic acid ( SAHA ) , a histone deacetylase inhibitor , in patients ( pts ) with advanced leukemias or myelodysplastic syndromes ( MDS ) [ abstract ]

A Raza
J Clin Oncol • 2004

Phase II study of R 115777 , a farnesyl transferase inhibitor , in myelodysplastic syndrome

EJ Feldman
J Clin Oncol • 2004

Preliminary results [abstract

JE Karp
2004

Similar Papers

Loading similar papers…